LOXHD1 Gene Deafness Autosomal Recessive Type 77 Genetic Test
Genetic testing plays a crucial role in identifying and diagnosing various genetic conditions. One such condition is LOXHD1 gene deafness, also known as autosomal recessive type 77 (DFNB77). At DNA Labs UAE, we offer a comprehensive genetic test for LOXHD1 gene deafness, providing valuable insights into this condition.
Test Details
The LOXHD1 gene is associated with autosomal recessive type 77 (DFNB77) deafness. This means that in order to be affected by this condition, an individual must inherit two copies of the mutated LOXHD1 gene, one from each parent. Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously, providing accurate and detailed results.
Components
- Test Name: LOXHD1 Gene Deafness Autosomal Recessive Type 77 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to undergoing the LOXHD1 gene deafness test, it is important to provide the clinical history of the patient. If the patient is also going for the SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the SLC52A2 gene. This will help in understanding the inheritance pattern and identifying any potential risk factors.
Benefits of NGS Genetic Testing
NGS genetic testing allows for the identification of specific genetic mutations causing DFNB77. This not only aids in the diagnosis of individuals with LOXHD1 gene deafness but also provides valuable information for genetic counseling. Additionally, the results of the test can guide treatment options and interventions, ensuring personalized care for each patient.
At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our state-of-the-art technology and experienced team of professionals ensure that you receive the highest quality results. Contact us today to schedule your LOXHD1 gene deafness autosomal recessive type 77 genetic test.
Test Name | LOXHD1 Gene Deafness autosomal recessive type 77 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A12 |
Test Details |
The LOXHD1 gene is associated with a type of deafness known as autosomal recessive type 77 (DFNB77). This genetic condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) in order to be affected. NGS (Next-Generation Sequencing) genetic testing refers to a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of LOXHD1 gene deafness, an NGS genetic test would involve sequencing the LOXHD1 gene to identify any mutations or variations that may be causing the deafness. By identifying the specific genetic mutation causing DFNB77, NGS genetic testing can help in diagnosing individuals with this condition, providing valuable information for genetic counseling, and potentially guiding treatment options or interventions. |